These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 19346430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW.
    Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 6. Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension.
    Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW.
    Kidney Int; 2008 Nov; 74(9):1192-6. PubMed ID: 18716604
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ACE inhibitors, left ventricular mass and renal cyst growth in ADPKD.
    Schrier RW.
    Pharmacol Res; 2016 Dec; 114():166-168. PubMed ID: 27794499
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials.
    Xue C, Zhou C, Dai B, Yu S, Xu C, Mao Z, Ye C, Chen D, Zhao X, Wu J, Chen W, Mei C.
    Oncotarget; 2015 Dec 15; 6(40):42515-29. PubMed ID: 26636542
    [Abstract] [Full Text] [Related]

  • 13. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
    Miller RH, Lehmkuhl LB, Smeak DD, DiBartola SP, Radin J.
    Am J Vet Res; 1999 Dec 15; 60(12):1516-25. PubMed ID: 10622161
    [Abstract] [Full Text] [Related]

  • 14. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
    Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, Schrier RW.
    Clin J Am Soc Nephrol; 2014 May 15; 9(5):889-96. PubMed ID: 24721893
    [Abstract] [Full Text] [Related]

  • 15. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
    Chapman AB.
    Clin J Am Soc Nephrol; 2008 Jul 15; 3(4):1197-204. PubMed ID: 18579674
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin blockade in late autosomal dominant polycystic kidney disease.
    Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD, HALT-PKD Trial Investigators.
    N Engl J Med; 2014 Dec 11; 371(24):2267-76. PubMed ID: 25399731
    [Abstract] [Full Text] [Related]

  • 19. No effect of enalapril on progression in autosomal dominant polycystic kidney disease.
    van Dijk MA, Breuning MH, Duiser R, van Es LA, Westendorp RG.
    Nephrol Dial Transplant; 2003 Nov 11; 18(11):2314-20. PubMed ID: 14551359
    [Abstract] [Full Text] [Related]

  • 20. Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension.
    Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Yamada S, Ueda Y, Koide H.
    Am J Med Sci; 2012 Jan 11; 343(1):46-51. PubMed ID: 21760473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.